Deferasorox Granule
Product Images NDC 72205-075

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Deferasorox (NDC 72205-075). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Novadoz Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

180mg-carton-label (180mg Carton Label)

180mg-carton-label (180mg Carton Label)
This text seems to be a medication label for Deferasirox Oral Granules that come in sachets and are equivalent to 180 mg of deferasiox. Each sachet contains 325 mg granules. The medication guide should be dispensed to each patient by the pharmacist. The manufacturer is Novadoz and the NDC number is 7220807530. The dosage instructions are not readily available. There is also information on the number of sachets contained in the packaging (30 sachets).*
FDA Label Image

180mg-packet-label (180mg Packet Label)

FDA Label Image

360mg-carton-label (360mg Carton Label)

360mg-carton-label (360mg Carton Label)
Deferasirox Oral Granules are a medication that comes in sachets. Each sachet contains 650 mg granules equivalent to 360 mg of deferasirox. These granules are only for oral use and should be protected from moisture. The recommended storage temperature ranges from 20 to 25° Celsius (68 to 77° Fahrenheit) with excursions permitted between 15 to 30° Celsius (59 to 86° Fahrenheit). The medication guide should be given to each patient along with the sachets by the dispensing pharmacist. This medication should be kept out of reach of children. The manufacturer is VSN Labordres Prvae Limited, located in Toangara, India, and it is distributed by Novadoz Pharmaceuticals LLC located in New Jersey, USA, with an NDC code of 72205-076-30.*
FDA Label Image

360mg-packet-label (360mg Packet Label)

FDA Label Image

90mg Crtn Label

90mg Crtn Label
This is a medication guide for Deferasirox oral granules, which is used to treat a high level of iron in the blood caused by multiple blood transfusions. The guide provides instructions on how to properly administer the medication, how to store it, and its usual dosage. It also includes the drug's manufacturer and the drug code.*
FDA Label Image

90mg Sachet Label

FDA Label Image

Def-str (Def Structure)

FDA Label Image

Def-str (Deferasirox Figure)

Def-str (Deferasirox Figure)
This table shows the change in liveriron content and serum ferritin in response to different doses of Deferasirox. There were 108 patients in one group and 115 in another. The dosage administered was 30 mg/kg/day. However, without further context, it is not possible to infer further information from the data provided.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.